Background: The increase in life expectancy has led to profound changes in disease prevention and health maintenance. Because of the impact of dysbiosis on the host's health, it is worth considering microbiome-targeted therapies to attenuate or delay age-related perturbations.
Aim: The aim of the present review was to systematically evaluate the impact of probiotics, prebiotics, and synbiotics on the major events that affect individuals aged 65 or older.
Methods: We performed a literature search in MEDLINE and the Cochrane Central Register of Controlled Trials. Randomized Clinical Trials (RCTs) performed on old people and published between 2009 and 2019 were included.
Results: Nine RCTs and 1 secondary analysis (n = 475, 55.8% female) were eligible for inclusion and retrieved in this systematic review. Overall, most interventions resulted in improvements in certain parameters when compared to control (glucose homeostasis, cognitive function, frailty phenotype, gut microbiota profile, immune parameters), while others remained unvariable.
Conclusions: The use of probiotics and prebiotics raises a great opportunity to modulate the process of aging and looks promising for health prevention in old adults. However, more RCTs in subjects older than 65 years are needed to elucidate the suitability of these supplementations and establish the underlying potential mechanisms.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.exger.2022.111809 | DOI Listing |
Food Sci Nutr
December 2024
Nutrition and Food Sciences Department, Faculty of Home Economics Menoufia University Shibin el Kom Egypt.
Clin Nutr
December 2024
Department of Nutrition and Health, Key Laboratory of Functional Dairy, Co-constructed by Ministry of Education and Beijing Government, China Agricultural University, Beijing 100193, China. Electronic address:
Background And Aims: Combining probiotics and prebiotics in synbiotics may present a synergistic approach to improve type 2 diabetes mellitus (T2DM); however, further evidence is required to establish the comparative efficacy of synbiotics versus probiotics. This study aimed to evaluate the effects of Bifidobacterium animalis subsp. lactis MN-Gup (MN-Gup) and a synbiotic mixture of MN-Gup and galactooligosaccharide (MN-Gup-GOS) on glycemic control in T2DM patients and explore possible mechanisms.
View Article and Find Full Text PDFJHEP Rep
January 2025
Massachusetts General Hospital, Division of Gastroenterology, Boston, MA, USA.
The last two decades have witnessed an explosion of microbiome research, including in hepatology, with studies demonstrating altered microbial composition in liver disease. More recently, efforts have been made to understand the association of microbiome features with clinical outcomes and to develop therapeutics targeting the microbiome. While microbiome therapeutics hold much promise, their unique features pose certain challenges for the design and conduct of clinical trials.
View Article and Find Full Text PDFIntroduction: Anemia is a common global health problem, particularly in impoverished regions, with a high incidence rate. The condition is multifactorial, with iron deficiency being one of the most prevalent causes. Current treatment for anemia often relies on iron supplements or erythropoiesis-stimulating agents, although these therapies may show limited efficacy for some patients.
View Article and Find Full Text PDFmSystems
December 2024
Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul, South Korea.
Onions are well-known vegetables that offer various health benefits. This study explores the impact of onion extracts on gut microbiome using an fecal incubation model and metabolome analysis. Fecal samples were collected from 19 healthy donors and incubated in the presence or absence of onion extracts for 24 h.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!